- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 1104-1118 of
1,230 results
1227 Exhibit: REG NDNY 00000004 Gilead Sciences Inc Form 10 K 26
Document
IPR2021-00816, No. 1227-2 Exhibit - REG NDNY 00000004 Gilead Sciences Inc Form 10 K 26 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1210 Exhibit: Deposition of Michael J Miller, IPR2021 00816
Document
IPR2021-00816, No. 1210-2 Exhibit - Deposition of Michael J Miller, IPR2021 00816 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1227 Exhibit: REG NDNY 00000004 Gilead Sciences Inc Form 10 K 56
Document
IPR2021-00816, No. 1227-5 Exhibit - REG NDNY 00000004 Gilead Sciences Inc Form 10 K 56 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1105 Exhibit: Reply Declaration of Horst Koller
Document
IPR2021-00816, No. 1105-2 Exhibit - Reply Declaration of Horst Koller (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1242 Exhibit: R DeForest McDuff, Ryan C Andrews, and Matt D Brundage, Thinking...
Document
IPR2021-00816, No. 1242 Exhibit - R DeForest McDuff, Ryan C Andrews, and Matt D Brundage, Thinking Economically about Commercial Success, Landslide, 94 1 5 MarApr 2017 (P.T.A.B. Apr. ...
|
|
Cite Document
1237 Exhibit: ���Highlights of Prescribing Information,��� Eylea, FDA, revised Octobe...
Document
IPR2021-00816, No. 1237 Exhibit - ���Highlights of Prescribing Information,��� Eylea, FDA, revised October 2014 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1108 Exhibit: Declaration of Joel M Cohen
Document
IPR2021-00816, No. 1108 Exhibit - Declaration of Joel M Cohen (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1244 Exhibit: Ernst R Berndt et al, Information, Marketing, and Pricing in the US An...
Document
IPR2021-00816, No. 1244 Exhibit - Ernst R Berndt et al, Information, Marketing, and Pricing in the US Antiulcer Drug Market, The American Economic Review 852 102 103 1995 (P.T.A.B. Apr. 15...
|
|
Cite Document
1107 Exhibit: Declaration of Lisa Cameron
Document
IPR2021-00816, No. 1107-2 Exhibit - Declaration of Lisa Cameron (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1198 Exhibit: Excerpt of Research Design Model Specification,��� Reference Manua...
Document
IPR2021-00816, No. 1198 Exhibit - Excerpt of Research Design Model Specification,��� Reference Manual on Scientific Evidence, 3rd edition, National AcademicsPress, 2011 (P.T.A.B. Apr. 15, 2...
|
|
Cite Document
1189 Exhibit: US FDA approves updated Novartis Beovu�� label, to include addition...
Document
IPR2021-00816, No. 1189 Exhibit - US FDA approves updated Novartis Beovu�� label, to include additional safety information, Novartis press release, June 11, 2020 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1227 Exhibit: REG NDNY 00000004 Gilead Sciences Inc Form 10 K 46
Document
IPR2021-00816, No. 1227-4 Exhibit - REG NDNY 00000004 Gilead Sciences Inc Form 10 K 46 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1100 Exhibit: Declaration of James Agalloco
Document
IPR2021-00816, No. 1100-2 Exhibit - Declaration of James Agalloco (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1201 Exhibit: Highlights of Prescribing Information, Lucentis, FDA, revised January...
Document
IPR2021-00816, No. 1201 Exhibit - Highlights of Prescribing Information, Lucentis, FDA, revised January 2017 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1182 Exhibit: Mali Okada et al, Nonadherence or Nonpersistence to Intravitreal Inje...
Document
IPR2021-00816, No. 1182 Exhibit - Mali Okada et al, Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age Related Macular Degeneration A Mixed Methods Sys...
|
|
Cite Document
